Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation
Multiple Sclerosis Journal · 2024
DOI: 10.1177/13524585231205970 ↗Kurz gefasst
Editorial in der Zeitschrift Multiple Sclerosis Journal, 2024. Verfasst von Bassem I Yamout und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Institute, Harley Street Medical Centre, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Drugs, Essential. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurology Institute, Harley Street Medical Centre, Abu Dhabi, United Arab Emirates.
- Neurology Department, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.
- Multiple Sclerosis International Federation, London, UK.
- Aga Khan University Medical College in East Africa, Nairobi, Kenya.
ORCID-Profile: Shanthi Viswanathan, Joanna Laurson-Doube, Dilraj Sokhi
Zitieren
APA
Yamout, B. I., Viswanathan, S., Laurson-Doube, J., & Sokhi, D. (2024). Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585231205970
Vancouver
Yamout BI, Viswanathan S, Laurson-Doube J, Sokhi D. Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation. Multiple Sclerosis Journal. 2024. doi:10.1177/13524585231205970
BibTeX
@article{Yamout2024,
author = {Yamout, Bassem I and Viswanathan, Shanthi and Laurson-Doube, Joanna and Sokhi, Dilraj},
title = {Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation},
journal = {Multiple Sclerosis Journal},
year = {2024},
doi = {10.1177/13524585231205970}
}
EUVIMED